IVA vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

IVA

35.5
AI Score
VS
SYRE Wins

SYRE

66.4
AI Score

Investment Advisor Scores

IVA

36score
Recommendation
SELL

SYRE

66score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IVA SYRE Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -89.9% 0.0% SYRE
Earnings Growth 0.0% -99.7% IVA
Tradestie Score 35.5/100 66.4/100 SYRE
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD SYRE

Relative Price Performance (Last 90 Days)

IVA 1M: -14.1% · 3M: +5.8% SYRE 1M: -13.0% · 3M: +12.2%

Current Technical Phase

IVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 31

RSI (14): 30.6 · Price: $4.02

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $90.60

Fundamentals Snapshot

Metric IVA SYRE
Market Cap
Forward P/E -4.8 -25.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% 0.0%
Gross Margin 1.0%
Operating Margin -67.1% 0.0%
EPS -2.05 -1.96
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.